Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Shares Outstanding (Weighted Average): 2016-2025

Historic Shares Outstanding (Weighted Average) for Anaptysbio (ANAB) over the last 9 years, with Sep 2025 value amounting to $28.0 million.

  • Anaptysbio's Shares Outstanding (Weighted Average) rose 2.00% to $28.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.0 million, marking a year-over-year increase of 2.00%. This contributed to the annual value of $30.4 million for FY2024, which is 14.50% up from last year.
  • Per Anaptysbio's latest filing, its Shares Outstanding (Weighted Average) stood at $28.0 million for Q3 2025, which was down 4.71% from $29.4 million recorded in Q2 2025.
  • In the past 5 years, Anaptysbio's Shares Outstanding (Weighted Average) registered a high of $30.7 million during Q1 2025, and its lowest value of $26.5 million during Q2 2023.
  • Over the past 3 years, Anaptysbio's median Shares Outstanding (Weighted Average) value was $27.4 million (recorded in 2024), while the average stood at $28.0 million.
  • As far as peak fluctuations go, Anaptysbio's Shares Outstanding (Weighted Average) declined by 6.53% in 2023, and later rose by 14.59% in 2025.
  • Quarterly analysis of 5 years shows Anaptysbio's Shares Outstanding (Weighted Average) stood at $27.5 million in 2021, then increased by 3.36% to $28.4 million in 2022, then declined by 6.53% to $26.6 million in 2023, then rose by 14.50% to $30.4 million in 2024, then grew by 2.00% to $28.0 million in 2025.
  • Its last three reported values are $28.0 million in Q3 2025, $29.4 million for Q2 2025, and $30.7 million during Q1 2025.